140
Participants
Start Date
April 14, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
May 31, 2027
Placebo
A substance that is designed to have no therapeutic value
MM120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
WITHDRAWN
Spectrum Neuroscience and Treatment Institute, New York
NOT_YET_RECRUITING
Adams Clinical Harlem, New York
NOT_YET_RECRUITING
Berman Clinical, New York
NOT_YET_RECRUITING
Columbia - New York State Psychiatric Institute, New York
WITHDRAWN
Scranton Medical Institute, LLC, Scranton
RECRUITING
Adams Clinical Philadelphia, Philadelphia
RECRUITING
Sheppard Pratt, Baltimore
RECRUITING
Clinical Neuroscience Solutions, Inc, Jacksonville
RECRUITING
Clinical Neuroscience Solutions, Inc, Orlando
RECRUITING
Charter Research, Orlando
WITHDRAWN
Segal Trials- Center for Psychedelic Research, Lauderhill
NOT_YET_RECRUITING
Clinical Neuroscience Solutions, Inc, Memphis
RECRUITING
Neuro-Behavioral Clinical Research, Canton
RECRUITING
University of Cincinnati, Cincinnati
RECRUITING
Uptown Research, Chicago
RECRUITING
University of Missouri, Columbia
RECRUITING
Preferred Research Partners, Inc, Little Rock
ACTIVE_NOT_RECRUITING
Preferred Research Partner, Fayetteville
NOT_YET_RECRUITING
FutureSearch Trials of Dallas, Dallas
RECRUITING
Dell Medical School, University of Texas at Austin, Austin
RECRUITING
Austin Clinical Trial Partners, Austin
RECRUITING
Mountain View Clinical Research, Inc, Denver
RECRUITING
Cedar Clinical Research, Murray
NOT_YET_RECRUITING
Psychedelic Science Institute, Santa Monica
RECRUITING
Kadima Neuropsychiatry Institute, La Jolla
NOT_YET_RECRUITING
Copley Clinical, Boston
RECRUITING
Adams Clinical Boston, Boston
RECRUITING
Cenexel HRI, Berlin
RECRUITING
Memory Clinic, Inc, Bennington
Mind Medicine, Inc.
INDUSTRY